Quick Answer
CervoMed Inc. reported Research And Development Expense of $21.82 million for the year ending 2025.
- CervoMed Inc. showed an increase of +16.1% in Research And Development Expense from 2024 to 2025.
- This data is from CervoMed Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), CervoMed Inc.'s Research And Development Expense has grown by 6,262.2%.
- Historical annual values: Fiscal year 2025: $21.82 million | Fiscal year 2024: $18.80 million | Fiscal year 2023: $8.44 million | Fiscal year 2022: $1.34 million | Fiscal year 2021: $8.50 million | Fiscal year 2020: $9.43 million | Fiscal year 2019: $6.62 million | Fiscal year 2018: $5.75 million | Fiscal year 2017: $5.09 million | Fiscal year 2016: $7.25 million | Fiscal year 2015: $3.88 million | Fiscal year 2014: $2.86 million | Fiscal year 2013: $342.9 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: